Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C30H32FNO13 |
| Molecular Weight | 633.5724 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 7 / 7 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=CC2=C1C(=O)C3=C(C2=O)C(O)=C4C[C@](O)(C[C@H](O[C@@H]5O[C@@H](C)[C@@H](O)[C@@H](O)[C@H]5F)C4=C3O)C(=O)COC(=O)CCN
InChI
InChIKey=CKXIPXAIFMTQCS-LRDUUELOSA-N
InChI=1S/C30H32FNO13/c1-11-23(35)28(40)22(31)29(44-11)45-15-9-30(41,16(33)10-43-17(34)6-7-32)8-13-19(15)27(39)21-20(25(13)37)24(36)12-4-3-5-14(42-2)18(12)26(21)38/h3-5,11,15,22-23,28-29,35,37,39-41H,6-10,32H2,1-2H3/t11-,15-,22+,23+,28-,29-,30-/m0/s1
| Molecular Formula | C30H32FNO13 |
| Molecular Weight | 633.5724 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 7 / 7 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
GALARUBICIN (DA-125) is an anthracycline derivative with anticancer activity, containing fluorine. The mechanism of action of this drug lies in inhibition of nucleic acid synthesis through intercalation with DNA. Because the structure and DNA-intercalating properties of DA-125 are similar to adriamycin, the cytotoxic effects of the two anthracyclines probably have similar biochemical mechanisms. Preclinical studies suggest that it may have greater activity and less cardiac toxicity than adriamycin. In a rodent study, administration of D-125 in higher dose levels (25 to 50 mg/kg) has been shown to result in testicular damage.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:17:12 GMT 2025
by
admin
on
Mon Mar 31 18:17:12 GMT 2025
|
| Record UNII |
6F39648E92
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C1594
Created by
admin on Mon Mar 31 18:17:12 GMT 2025 , Edited by admin on Mon Mar 31 18:17:12 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C81422
Created by
admin on Mon Mar 31 18:17:12 GMT 2025 , Edited by admin on Mon Mar 31 18:17:12 GMT 2025
|
PRIMARY | |||
|
6F39648E92
Created by
admin on Mon Mar 31 18:17:12 GMT 2025 , Edited by admin on Mon Mar 31 18:17:12 GMT 2025
|
PRIMARY | |||
|
100000087256
Created by
admin on Mon Mar 31 18:17:12 GMT 2025 , Edited by admin on Mon Mar 31 18:17:12 GMT 2025
|
PRIMARY | |||
|
CHEMBL2106451
Created by
admin on Mon Mar 31 18:17:12 GMT 2025 , Edited by admin on Mon Mar 31 18:17:12 GMT 2025
|
PRIMARY | |||
|
7826
Created by
admin on Mon Mar 31 18:17:12 GMT 2025 , Edited by admin on Mon Mar 31 18:17:12 GMT 2025
|
PRIMARY | |||
|
SUB02302MIG
Created by
admin on Mon Mar 31 18:17:12 GMT 2025 , Edited by admin on Mon Mar 31 18:17:12 GMT 2025
|
PRIMARY | |||
|
195612-80-7
Created by
admin on Mon Mar 31 18:17:12 GMT 2025 , Edited by admin on Mon Mar 31 18:17:12 GMT 2025
|
PRIMARY | |||
|
114759
Created by
admin on Mon Mar 31 18:17:12 GMT 2025 , Edited by admin on Mon Mar 31 18:17:12 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |